These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17802765)

  • 1. [Local and systemic immunological disorders in proliferative vitreoretinopathy].
    Krivosheina OI
    Vestn Oftalmol; 2007; 123(4):51-4. PubMed ID: 17802765
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of severity of immune disorders and prognosis of the development of pyo-septic complications in patients with emergency surgery pathology].
    Bulava MM; Borovkova NV; Khvatov VB; Godkov MA
    Vestn Khir Im I I Grek; 2009; 168(3):10-6. PubMed ID: 19663272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of cellular and humoral immunity in tropical malaria].
    Nikiforov ND; Popov AF; Sanin BI; Morokov VS
    Klin Med (Mosk); 2000; 78(2):33-5. PubMed ID: 10723149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of immune system in development of structural changes in colonic mucosa in diverticulosis].
    Levchenko SV; Gudkova RB; Potapova AI; Parfenov AI; Rogozina VA; Lazebnik LB
    Ter Arkh; 2011; 83(2):29-33. PubMed ID: 21516846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Onset and progression of proliferative vitreoretinopathy as viewed from the system approach].
    Krivosheina OI; Zapuskalov IV
    Vestn Oftalmol; 2004; 120(4):44-6. PubMed ID: 15384853
    [No Abstract]   [Full Text] [Related]  

  • 6. [The state of immune status in patients with chronic periodontitis before and after combined treatment with physical methods].
    Kutateladze NS
    Georgian Med News; 2009 Jan; (166):32-8. PubMed ID: 19202215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proliferative vitreoretinopathy: pathogenetic factors and development peculiarities].
    Krivosheina OI
    Vestn Oftalmol; 2003; 119(3):47-50. PubMed ID: 12822340
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pathomorphology of membranes appearing in proliferative vitreoretinopathies].
    Laudańska-Olszewska I; Omulecki W; Dziegielewski K; Pikulski Z; Omulecka A
    Klin Oczna; 2006; 108(1-3):28-31. PubMed ID: 16883935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proliferative vitreoretinopathy--selected issues concerning morphology and pathophysiology].
    Laudańska-Olszewska I; Omulecki W
    Klin Oczna; 2006; 108(1-3):87-9. PubMed ID: 16883949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunological aspects of pathogenesis of stomatological constructional materials intolerance].
    Tsimbalistov AV; Mikhaĭlova ES; Shabashova NV; Frolova EV; Zueva EV
    Stomatologiia (Mosk); 2006; 85(4):37-40. PubMed ID: 17047610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cell-mediated and humoral immunity in human rabies].
    Fang Z; Zuo D; Qian H
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(3):279-80. PubMed ID: 9868138
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental simulation of proliferatice vutreoretinopathy].
    Krivosheina OI; Zapuskalov IV
    Vestn Oftalmol; 2007; 123(1):44-8. PubMed ID: 17361806
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bioactive substances in the regulation of vitreoretinal proliferation].
    Balashova LM
    Vestn Oftalmol; 1995; 111(3):31-3. PubMed ID: 7483202
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biologically active substances and their involvement in the pathogenesis of proliferative vitreoretinopathy].
    Krivosheina OI
    Vestn Oftalmol; 2005; 121(6):53-5. PubMed ID: 16405070
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunological disorders and correction of them in surgical patients with atherosclerosis obliterance].
    Zemskov AM; Samodaĭ VG
    Khirurgiia (Mosk); 2006; (6):38-41. PubMed ID: 16883238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immune disorders in erosive and ulcerative lesions to the gastroduodenal mucosa].
    Maev IV; Gadzhieva MG; Ovchinnikova NI
    Klin Med (Mosk); 2004; 82(12):4-9. PubMed ID: 15732710
    [No Abstract]   [Full Text] [Related]  

  • 17. Specifying helper T cell fates during immunity.
    Chang JT; Reiner SL
    J Pediatr Gastroenterol Nutr; 2008 Apr; 46 Suppl 1():E19-20. PubMed ID: 18354322
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms in proliferative vitreoretinopathy.
    Kim IK; Arroyo JG
    Ophthalmol Clin North Am; 2002 Mar; 15(1):81-6. PubMed ID: 12064085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular immunity impaired among patients on left ventricular assist device for 6 months.
    Kimball PM; Flattery M; McDougan F; Kasirajan V
    Ann Thorac Surg; 2008 May; 85(5):1656-61. PubMed ID: 18442560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of disease: the evolving role of regulatory T cells in atherosclerosis.
    George J
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):531-40. PubMed ID: 18607396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.